Unrestricted Institutional Support for Medical Schools

By providing unrestricted funds to nonprofit organizations, we strengthen their capacity and effectiveness, because grantees are best positioned to determine how resources can create the greatest impact based on their lived expertise and local context. This strategy centers on trust-based philanthropy, where funders provide general operating or program support without restrictions, enabling grantees to allocate resources according to their highest priorities. It contrasts with targeted or project-specific funding by emphasizing organizational autonomy, adaptability, and long-term sustainability over external control. The shared belief across these organizations is that frontline leaders—closer to the communities served—make more effective resource decisions than distant funders.

By applying venture philanthropy principles to fund high-risk, high-reward research, we accelerate breakthrough therapies, because strategic, flexible investment can de-risk early-stage science and attract further capital. This strategy involves treating philanthropic funding like venture capital—targeting innovative, early-stage research with high transformative potential, often in environments where traditional funders hesitate to invest. It distinguishes itself from conventional grantmaking by emphasizing financial discipline, reinvestment of returns, and active management akin to venture capital, as seen in both EB Research Partnership and the Alzheimer’s Drug Discovery Foundation.

By integrating medical, psychological, social, and spiritual supports within a unified, person-centered framework, organizations improve recovery outcomes, because addressing the full spectrum of an individual’s needs leads to more sustainable engagement and resilience than isolated interventions. This strategy centers on treating individuals as whole persons rather than focusing on discrete symptoms or diagnoses. It distinguishes itself from narrower clinical models by intentionally weaving together behavioral health, social services, family systems, peer support, and trauma-informed practices into a coordinated continuum of care. Unlike single-modality approaches, the Holistic Integration Model assumes that lasting recovery emerges from aligning multiple domains of well-being—biological, emotional, relational, and systemic—within a culturally responsive and client-driven process.

By integrating care across disciplines and centering patient agency, preferences, and lived experience, organizations produce improved health outcomes and engagement, because holistic, coordinated, and personalized approaches address the full spectrum of medical, emotional, and social needs while fostering trust and adherence. This strategy unifies models that combine structural integration of services—such as co-located care, multidisciplinary teams, and home-based delivery—with a deep commitment to patient partnership, shared decision-making, and individualized planning. What distinguishes it from narrower operational models is its dual focus on system-level coordination and patient-level empowerment, treating both clinical integration and personal agency as essential to effective care. Unlike purely logistical or educational approaches, this strategy assumes that sustainable health improvement arises from aligning clinical expertise with the patient’s values, environment, and life

By deploying competitive, expert-informed funding mechanisms to individuals and institutions in ophthalmology and vision science, advance high-impact research and innovation, because structured investment in scientific excellence accelerates breakthroughs and improves clinical outcomes. This strategy centers on using rigorous, expertise-driven grantmaking to identify and scale the most promising research opportunities in vision science. It distinguishes itself by combining peer review, milestone accountability, and strategic partnerships to de-risk innovation and amplify impact, rather than providing undirected or purely educational support. Unlike broad institutional funding, it emphasizes performance, scientific rigor, and systemic capacity building across both individual researchers and leading departments.